The Cartiva implant is a synthetic cartilage device that was approved by the FDA in 2014 to treat arthritis in the big toe. However, there have been reports of high failure rates and other complications associated with the implant.
A post-market study found that patients with the Cartiva implant had a failure rate of up to 64%. The most common reasons for failure were implant migration and implant fracture. Other complications associated with the implant include persistent pain, infection, bone loss, and cyst formation.
As a result of these problems, there have been a number of lawsuits filed against the manufacturer of the Cartiva implant, Cartiva, Inc., and its parent company, Wright Medical Group. The lawsuits allege that the implant is defectively designed and that the manufacturers knew or should have known about the high failure rates and other problems with the implant, but failed to warn patients about these risks.
The lawsuits are still pending, but if the plaintiffs are successful, they could be awarded damages for their medical expenses, pain and suffering, and other losses.
If you have had the Cartiva implant and have experienced problems with it, you may be eligible to file a lawsuit. You should speak to an attorney to discuss your legal options.
Here are some of the common side effects of the Cartiva implant:
- Persistent pain
- Infection
- Implant fracture
- Bone loss
- Cyst formation
- Silastic granulomas
- Transfer metatarsalgia
If you have experienced any of these side effects after receiving a Cartiva implant, you should talk to your doctor. You may also want to consider filing a lawsuit against the manufacturer.
